The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
The Food and Drug Administration is scrutinizing the common practice of giving coronavirus and flu shots together, signaling a reversal of years of federal guidance and a broader crackdown on ...
A crucial March meeting of vaccine advisors to the Food and Drug Administration has been canceled without explanation, a member of the advisory panel told CNBC on Wednesday. Stream Los Angeles News ...
The Infectious Diseases Society of America updates flu and RSV vaccine guidelines, emphasizing safety for immunocompromised patients during respiratory virus season. The Infectious Diseases Society of ...
MedPage Today on MSN
Intranasal Flu Vaccine Shows Promise in Early Trial
For intramuscular vaccines, the standard hemagglutination inhibition (HAI) titer used to infer immune protection is at least ...
FDA chief Mary Makary, MD, MPH, and his boss HHS Secretary Robert F. Kennedy Jr. are locked in a power struggle over vaccine ...
Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
The 2024-2025 influenza season saw high severity, with 56 million symptomatic cases and 770,000 hospitalizations, mainly affecting older adults. Older adults accounted for 77% of hospitalizations, ...
This year’s respiratory virus season comes with some unique challenges. Experts and providers say they’re worried about how ...
A crucial March meeting of vaccine advisors to the Food and Drug Administration has been canceled without explanation, a member of the advisory panel told CNBC on Wednesday. The meeting of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results